APLM
Apollomics Inc. Class A Ordinary Shares
$6.920+-0.000 (-0.000%)
リアルタイム価格
価格チャート
Loading Chart...
主要指標
市場指標
始値
$6.920
高値
$6.920
安値
$6.920
出来高
0.00M
企業ファンダメンタルズ
取引統計
関連ニュース
GlobeNewswire
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
もっと見る
GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
もっと見る
